Kathryn Gregory - Net Worth and Insider Trading

Kathryn Gregory Net Worth

The estimated net worth of Kathryn Gregory is at least $180,774 dollars as of 2024-04-29. Kathryn Gregory is the Director of Carmell Corp and owns about 81,112 shares of Carmell Corp (CTCX) stock worth over $169,524. Kathryn Gregory is also the SVP, Chief Business Officer of Aileron Therapeutics Inc and owns about 2,250 shares of Aileron Therapeutics Inc (ALRN) stock worth over $11,250. Details can be seen in Kathryn Gregory's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kathryn Gregory has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).

Transaction Summary of Kathryn Gregory

To

Kathryn Gregory Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathryn Gregory owns 2 companies in total, including Aileron Therapeutics Inc (ALRN) , and Carmell Corp (CTCX) .

Click here to see the complete history of Kathryn Gregory’s form 4 insider trades.

Insider Ownership Summary of Kathryn Gregory

Ticker Comapny Transaction Date Type of Owner
ALRN Aileron Therapeutics Inc 2019-08-13 SVP & Chief Business Officer
CTCX Carmell Corp 2023-12-15 director

Kathryn Gregory Latest Holdings Summary

Kathryn Gregory currently owns a total of 2 stocks. Among these stocks, Kathryn Gregory owns 81,112 shares of Carmell Corp (CTCX) as of December 15, 2023, with a value of $169,524 and a weighting of 93.78%. Kathryn Gregory also owns 2,250 shares of Aileron Therapeutics Inc (ALRN) as of August 13, 2019, with a value of $11,250 and a weighting of 6.22%.

Latest Holdings of Kathryn Gregory

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTCX Carmell Corp 2023-12-15 81,112 2.09 169,524
ALRN Aileron Therapeutics Inc 2019-08-13 2,250 5.00 11,250

Holding Weightings of Kathryn Gregory


Kathryn Gregory Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathryn Gregory has made a total of 3 transactions in Carmell Corp (CTCX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Carmell Corp is the acquisition of 1,130 shares on December 15, 2023, which cost Kathryn Gregory around $4,317.

According to the SEC Form 4 filings, Kathryn Gregory has made a total of 1 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 2,250 shares on August 13, 2019, which cost Kathryn Gregory around $29,250.

Insider Trading History of Kathryn Gregory

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathryn Gregory Trading Performance

GuruFocus tracks the stock performance after each of Kathryn Gregory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathryn Gregory is -24.67%. GuruFocus also compares Kathryn Gregory's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathryn Gregory within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kathryn Gregory's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kathryn Gregory

Average Return

125.73%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.72 -24.67 16.39 125.73 32.39 -29.69
Relative Return to S&P 500(%) 11.42 -33.46 1.09 110.5 8.86 -43.2

Kathryn Gregory Ownership Network

Ownership Network List of Kathryn Gregory

No Data

Ownership Network Relation of Kathryn Gregory


Kathryn Gregory Owned Company Details

What does Aileron Therapeutics Inc do?

Who are the key executives at Aileron Therapeutics Inc?

Kathryn Gregory is the SVP & Chief Business Officer of Aileron Therapeutics Inc. Other key executives at Aileron Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and 10 percent owner Muneer A Satter .

Aileron Therapeutics Inc (ALRN) Insider Trades Summary

Over the past 18 months, Kathryn Gregory made no insider transaction in Aileron Therapeutics Inc (ALRN). Other recent insider transactions involving Aileron Therapeutics Inc (ALRN) include a net purchase of 5,301 shares made by James Brian Windsor ,

In summary, during the past 3 months, insiders sold 0 shares of Aileron Therapeutics Inc (ALRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aileron Therapeutics Inc (ALRN) were sold and 5,301 shares were bought by its insiders, resulting in a net purchase of 5,301 shares.

Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aileron Therapeutics Inc Insider Transactions

No Available Data

Kathryn Gregory Mailing Address

Above is the net worth, insider trading, and ownership report for Kathryn Gregory. You might contact Kathryn Gregory via mailing address: 305 Thayer Pond Road, Wilton Ct 06897.

Discussions on Kathryn Gregory

No discussions yet.